The progesterone vaginal ring (PVR) is a safe and effective method of contraception for lactating women. It is a priority medicine on the WHO’s Essential Medicines List and is included in the Medical Eligibility Criteria for family planning providers. Developed by the Population Council, the PVR is an intravaginal ring that provides women who breastfeed at least four times a day with a contraceptive option as early as four weeks after giving birth. The PVR provides a new option to reduce unmet need among new mothers, allow women to safely space their pregnancies, and improve the health of women and children around the world. This fact sheet serves as a call-to-action to fill critical gaps in postpartum family planning.
"Progesterone vaginal ring: A call-to-action to fill critical gaps in post-partum family planning," Advocacy brief. New York: Population Council, 2015.
The Progesterone Contraceptive Vaginal Ring: Expanding Contraceptive Options in Africa